...
【24h】

Feasibility and Safety of Laparoscopic Partial Splenectomy: A Systematic Review

机译:腹腔镜部分脾切除术的可行性和安全性:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundLaparoscopic partial splenectomy (LPS) is a challenging procedure. The aim of this review was to evaluate its feasibility, safety, and potential benefits.MethodsWe conducted a comprehensive review for the years 1995-2018 to retrieve all relevant articles.ResultsA total of 44 studies with 252 patients undergoing LPS were reviewed. Six studies described combined operations. Ranges of operative time and estimated blood loss were 50-225min and 0-1200ml, respectively. There are eight patients need blood transfusion in 231 patients with available data. The conversion rate was 3.6% (9/252). Overall, 27 patients (10.7%;27/252) developed postoperative or intraoperative complications. Overall mortality was 0% (0/252). The length of postoperative stay (POS) varied (1-11days). Among four comparative studies, one showed LPS could reduce POS than laparoscopic total splenectomy (LTS) (LTS 5.41.8days, LPS 4.2 +/- 0.8days, p=0.027) and complications (pleural effusion (LTS 9/22, LPS 0/15, p=0.005), splenic vein thrombosis (LTS 10/22, LPS 0/15, p=0.002)). Another comparative study showed LPS may benefit emergency patients. However, one comparative study showed LPS was associated with more pain, longer time to oral intake, and longer POS in children with hereditary spherocytosis. The fourth comparative study showed robotic subtotal splenectomy was comparable to laparoscopy in terms of POS and complication. The main benefits were lower blood loss, vascular dissection time, and a better evaluation of splenic remnant volume.Conclusionsp id=Par4 In early series of highly selected patients, LPS appears to be feasible and safe when performed by experienced laparoscopic surgeons.
机译:BackgroundArapharopic部分脾切除术(LPS)是一个具有挑战性的程序。本综述的目的是评估其可行性,安全性和潜在的福利。近期对1995 - 2018年的综合审查进行了全面的审查,以检索所有相关条款。审查了44例接受LPS的252例研究的44项研究。六项研究描述了组合操作。操作时间和估计失血的范围分别为50-225分钟和0-1200ml。有八名患者需要在231名可用数据患者中输血。转换率为3.6%(9/252)。总体而言,27名患者(10.7%; 27/252)开发出术后或术中并发症。总体死亡率为0%(0/252)。术后留下(POS)变化(1-11天)。在四种比较研究中,显示LPS可以减少比腹腔镜总脾切除术(LTS)(LTS 5.41.8days,LPS 4.2 +/- 0.8days,P = 0.027)和并发症(胸腔积液(LTS 9/22,LPS 0 / 15,P = 0.005),脾静脉血栓形成(LTS 10/22,LPS 0/15,P = 0.002))。另一种比较研究显示LPS可能会使急诊患者受益。然而,一个比较研究显示LPS与更高的疼痛有关,对口服摄入的更长的时间,以及具有遗传性球织毒性的儿童的更长的POS。第四研究表明机器人小斑块脾切除术与POS和并发症方面的腹腔镜检查相当。主要益处是较低的血液损失,血管解剖时间,以及对脾脏残留体积的更好评价。ConclusionsP ID = PAR4在早期的高度选择的患者中,LPS似乎是可行的,当由经验丰富的腹腔镜外科医生进行时似乎是可行和安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号